Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 39.474.847 | 479.681 | 4 | ||
2012 | 0 | 5.812.021 | 1.629.486 | 2 | ||
2011 | 0 | 6.000.000 | 67.376 | 1 |
Total number of partners: 348
Partner loyalty:
Frequent Partner: (> 2 projects): 27
Rare Partner: 321
Frequent / Rare Partner Ratio: 0.08
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-10-01 | A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer | GANNET53 | participant | 5.994.072 | 18 |
2013-10-01 | Collaborative European NeuroTrauma Effectiveness Research in TBI | CENTER-TBI | participant | 29.998.903 | 38 |
2013-08-01 | A Gateway to European Kidney Research Resources - KidneyConnect | KIDNEYCONNECT | participant | 499.978 | 17 |
2013-01-01 | Advanced Multidisciplinary Training in Molecular Bacteriology | AMBER | participant | 2.981.894 | 9 |
2012-04-01 | Rheumatoid Arthritis and Periodontal Inflammatory Disease (RAPID) | RAPID | participant | 4.312.151 | 14 |
2012-02-01 | Synthesis of mono-dithiolene molybdenum complexes and their evaluation as potential drugs for the treatment of human isolated sulfite oxidase deficiency | MOCOMODELS | participant | 1.499.870 | 3 |
2011-10-01 | Biomarker for Cardiovascular Risk Assessment in Europe | BiomarCaRE | participant | 6.000.000 | 30 |